Emerging pharma: Here’s your analytics roadmap to drive launches and long-term success

The market for launching new pharmaceutical and biotech products is crowded, competitive and data-driven. To hit the ground running and scale growth, pharma companies need a powerful analytics core. Yet many overlook a critical step for sustaining growth after launch: mapping the organization’s long-term analytics, data and system needs.

Usually, the oversight isn’t a result of a lack of effort or investment in launch planning. When preparing to release new products, commercial teams are under pressure to make early vendor, data and systems decisions and execute analytics projects quickly. Sometimes, the decisions made to support the organization’s immediate needs can constrain its data and system choices and limit growth options down the road. Based on our experience supporting more than 80% of U.S. biotech and pharmaceutical launches each year, companies without a foundational analytics roadmap face challenges when evolving or expanding capabilities as they mature.

Creating a roadmap is the most effective way to address this challenge in the 15-to-24-month window before launch, but it’s also a solution for companies eager to course-correct after they go to market. To prime the organization’s analytics foundation for growth, teams should first identify business needs and use cases, then map the data, analytics inputs and systems that support them.  Following this three-step process leads to better business decisions, greater efficiency, proven commercial success and a strategic plan for sequencing analytics data and systems at scale. Beyond improving the company’s return on its investment in analytics, a roadmap also prevents the many cycles of reworking that stall progress before and after launch.

For growth pharma companies building a scalable analytics foundation, ZAIDYN delivers immediate value and scales seamlessly as your needs evolve. ZAIDYN’s out-of-the-box, tiered approach optimizes cost, quality and stability. With automation, real-time insights and effortless integration, all your teams can act confidently together and achieve sustained success. See how you can leverage our ZAIDYN packages to fast-track your emerging biopharma company’s goals.

For growth pharma companies building a scalable analytics foundation, ZAIDYN delivers immediate value with the ability to instantly scale as your needs evolve. ZAIDYN’s out-of-the-box, tiered approach optimizes cost, quality and stability. With automation, real-time insights and effortless integration, all your teams can act confidently together and drive sustained success. See how you can leverage our ZAIDYN packages to fast-track your emerging biopharma company’s goals.